Inspira™ Approached by Large Medical Company to Evaluate Operation of their Key Product with INSPIRA™ ART100 – Results Exceed 100% at Maximum Flow

August 14, 2024

https://www.prnewswire.com/news-releases/inspira-approached-by-large-medical-company-to-evaluate-operation-of-their-key-product-with-inspira-art100–results-exceed-100-at-maximum-flow-302221019.html

RA’ANANA, Israel, Aug. 13, 2024 /PRNewswire/ — Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (“Inspira,” “Inspira Technologies,” or the “Company”), a trailblazer in life-support technology, today announced that it was approached by a leading medical technology company in the industry, to evaluate the operation of its proprietary key product in combination with the INSPIRA™ ART100 system. The evaluation was conducted by Inspira researchers. The test results exceeded 100% of the standard value for gas transfer at maximum flow, as indicated in the product’s specification when integrated with the INSPIRA™ ART100 system.

Read more at prnewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.